418 related articles for article (PubMed ID: 34801778)
1. European regulatory aspects of phage therapy: magistral phage preparations.
Verbeken G; Pirnay JP
Curr Opin Virol; 2022 Feb; 52():24-29. PubMed ID: 34801778
[TBL] [Abstract][Full Text] [Related]
2. Magistral Phage Preparations: Is This the Model for Everyone?
Pirnay JP; Verbeken G
Clin Infect Dis; 2023 Nov; 77(Suppl 5):S360-S369. PubMed ID: 37932120
[TBL] [Abstract][Full Text] [Related]
3. Quality and safety requirements for sustainable phage therapy products.
Pirnay JP; Blasdel BG; Bretaudeau L; Buckling A; Chanishvili N; Clark JR; Corte-Real S; Debarbieux L; Dublanchet A; De Vos D; Gabard J; Garcia M; Goderdzishvili M; Górski A; Hardcastle J; Huys I; Kutter E; Lavigne R; Merabishvili M; Olchawa E; Parikka KJ; Patey O; Pouilot F; Resch G; Rohde C; Scheres J; Skurnik M; Vaneechoutte M; Van Parys L; Verbeken G; Zizi M; Van den Eede G
Pharm Res; 2015 Jul; 32(7):2173-9. PubMed ID: 25585954
[TBL] [Abstract][Full Text] [Related]
4. Bacteriophages as Therapeutic and Prophylactic Means: Summary of the Soviet and Post Soviet Experiences.
Chanishvili N
Curr Drug Deliv; 2016; 13(3):309-23. PubMed ID: 27090515
[TBL] [Abstract][Full Text] [Related]
5. The Medicinal Phage-Regulatory Roadmap for Phage Therapy under EU Pharmaceutical Legislation.
Faltus T
Viruses; 2024 Mar; 16(3):. PubMed ID: 38543808
[TBL] [Abstract][Full Text] [Related]
6. Bacteriophage therapy as an alternative treatment for human infections. A comprehensive review.
Kakasis A; Panitsa G
Int J Antimicrob Agents; 2019 Jan; 53(1):16-21. PubMed ID: 30236954
[TBL] [Abstract][Full Text] [Related]
7. Stability of magistral phage preparations before therapeutic application in patients with chronic rhinosinusitis, sepsis, pulmonary, and musculoskeletal infections.
Uyttebroek S; Bessems L; Metsemakers W-J; Debaveye Y; Van Gerven L; Dupont L; Depypere M; Wagemans J; Lavigne R; Merabishvili M; Pirnay J-P; Devolder D; Spriet I; Onsea J
Microbiol Spectr; 2023 Dec; 11(6):e0290723. PubMed ID: 37819122
[TBL] [Abstract][Full Text] [Related]
8. Bacteriophage therapy: an overview and the position of Italian Society of Infectious and Tropical Diseases.
Cesta N; Di Luca M; Corbellino M; Tavio M; Galli M; Andreoni M
Infez Med; 2020 Sep; 28(3):322-331. PubMed ID: 32920567
[TBL] [Abstract][Full Text] [Related]
9. Phage Therapy: The Pharmacology of Antibacterial Viruses.
Danis-Wlodarczyk K; Dąbrowska K; Abedon ST
Curr Issues Mol Biol; 2021; 40():81-164. PubMed ID: 32503951
[TBL] [Abstract][Full Text] [Related]
10. The Magistral Phage.
Pirnay JP; Verbeken G; Ceyssens PJ; Huys I; De Vos D; Ameloot C; Fauconnier A
Viruses; 2018 Feb; 10(2):. PubMed ID: 29415431
[TBL] [Abstract][Full Text] [Related]
11. [Phage therapy, an additional strategy against multidrug-resistant bacteria].
Boniver M; Wotquenne P; Moutschen M; Rousseau AF
Rev Med Liege; 2022 Sep; 77(9):510-515. PubMed ID: 36082597
[TBL] [Abstract][Full Text] [Related]
12. Ameliorating the antimicrobial resistance crisis: phage therapy.
Saha D; Mukherjee R
IUBMB Life; 2019 Jul; 71(7):781-790. PubMed ID: 30674079
[TBL] [Abstract][Full Text] [Related]
13. Call for a dedicated European legal framework for bacteriophage therapy.
Verbeken G; Pirnay JP; Lavigne R; Jennes S; De Vos D; Casteels M; Huys I
Arch Immunol Ther Exp (Warsz); 2014 Apr; 62(2):117-29. PubMed ID: 24500660
[TBL] [Abstract][Full Text] [Related]
14. Fighting Pathogenic Bacteria on Two Fronts: Phages and Antibiotics as Combined Strategy.
Tagliaferri TL; Jansen M; Horz HP
Front Cell Infect Microbiol; 2019; 9():22. PubMed ID: 30834237
[TBL] [Abstract][Full Text] [Related]
15. Engineering therapeutic phages for enhanced antibacterial efficacy.
Meile S; Du J; Dunne M; Kilcher S; Loessner MJ
Curr Opin Virol; 2022 Feb; 52():182-191. PubMed ID: 34952266
[TBL] [Abstract][Full Text] [Related]
16. The Preclinical and Clinical Progress of Bacteriophages and Their Lytic Enzymes: The Parts are Easier than the Whole.
Abdelkader K; Gerstmans H; Saafan A; Dishisha T; Briers Y
Viruses; 2019 Jan; 11(2):. PubMed ID: 30678377
[TBL] [Abstract][Full Text] [Related]
17. Phage Therapy in the Twenty-First Century: Facing the Decline of the Antibiotic Era; Is It Finally Time for the Age of the Phage?
Hesse S; Adhya S
Annu Rev Microbiol; 2019 Sep; 73():155-174. PubMed ID: 31185183
[TBL] [Abstract][Full Text] [Related]
18. Bacteriophages: A Therapy Concept against Multi-Drug-Resistant Bacteria.
Rohde C; Wittmann J; Kutter E
Surg Infect (Larchmt); 2018; 19(8):737-744. PubMed ID: 30256176
[TBL] [Abstract][Full Text] [Related]
19. Phage Therapy for Antibiotic-Resistant Bacterial Infections.
Hatfull GF; Dedrick RM; Schooley RT
Annu Rev Med; 2022 Jan; 73():197-211. PubMed ID: 34428079
[TBL] [Abstract][Full Text] [Related]
20. A Wake-Up Call: We Need Phage Therapy Now.
Moelling K; Broecker F; Willy C
Viruses; 2018 Dec; 10(12):. PubMed ID: 30563034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
